Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Gross Profit (2020 - 2022)

iBio (IBIO) has disclosed Gross Profit for 3 consecutive years, with $46000.0 as the latest value for Q2 2022.

  • On a quarterly basis, Gross Profit fell 84.87% to $46000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $2.2 million, a 138.39% increase, with the full-year FY2022 number at $2.2 million, up 138.39% from a year prior.
  • Gross Profit was $46000.0 for Q2 2022 at iBio, down from $1.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.9 million in Q1 2022 to a low of -$192000.0 in Q1 2021.
  • A 3-year average of $390700.0 and a median of $237000.0 in 2020 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: tumbled 2020.0% in 2021, then surged 1086.98% in 2022.
  • iBio's Gross Profit stood at $494000.0 in 2020, then plummeted by 88.87% to $55000.0 in 2021, then fell by 16.36% to $46000.0 in 2022.
  • Per Business Quant, the three most recent readings for IBIO's Gross Profit are $46000.0 (Q2 2022), $1.9 million (Q1 2022), and $55000.0 (Q4 2021).